UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Journal of clinical oncology, 2005-02, Vol.23 (4), p.712-719

2005

Volltextzugriff (PDF)

Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1454-1459

2004

Volltextzugriff (PDF)

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4634-4642

2005

Volltextzugriff (PDF)

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3032-3038

2004

Volltextzugriff (PDF)

Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

Journal of clinical oncology, 2002-02, Vol.20 (3), p.630-637

Horning, S. J.

2002

Volltextzugriff (PDF)

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1244-1253

1999

Volltextzugriff (PDF)

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Blood, 2004-02, Vol.103 (3), p.777-783

2004

Volltextzugriff (PDF)

Treatment approaches to the low-grade lymphomas

Blood, 1994-02, Vol.83 (4), p.881-884

Horning, S J

1994

Volltextzugriff (PDF)

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

Blood, 2003-06, Vol.101 (11), p.4285-4289

2003

Volltextzugriff (PDF)

Natural history of and therapy for the indolent non-Hodgkin's lymphomas

Seminars in oncology, 1993-10, Vol.20 (5 Suppl 5), p.75-88

Horning, S J

1993

Volltextzugriff (PDF)

Burkitt's Lymphoma — The Message from Microarrays

The New England journal of medicine, 2006-06, Vol.354 (23), p.2495-2498

2006

Volltextzugriff (PDF)

Follicular lymphoma : Have we made any progress?

Annals of oncology, 2000, Vol.11, p.23-27

HORNING, S. J

2000

Volltextzugriff (PDF)

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

Blood, 2001-01, Vol.97 (2), p.404-409

2001

Volltextzugriff (PDF)

Something old, something few, something subjective, something déjà vu

Journal of clinical oncology, 2003-01, Vol.21 (1), p.1-2

Horning, Sandra J

2003

Volltextzugriff (PDF)

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease

Blood, 1997-02, Vol.89 (3), p.814-822

1997

Volltextzugriff (PDF)

Future directions in radioimmunotherapy for B-cell lymphoma

Seminars in oncology, 2003-12, Vol.30 (6 Suppl 17), p.29-34

Horning, Sandra J

2003

Volltextzugriff (PDF)

Introduction: ASCO-ESMO consensus statement on quality cancer care

Annals of oncology, 2006-07, Vol.17 (7), p.1061-1061

2006

Volltextzugriff (PDF)

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory hodgkin's disease : Analysis of the Stanford University results and prognostic indices

Blood, 1997-02, Vol.89 (3), p.801-813

1997

Volltextzugriff (PDF)

Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492

Journal of clinical oncology, 2000-03, Vol.18 (5), p.972-980

2000

Volltextzugriff (PDF)

Optimizing rituximab in B-cell lymphoma

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1056-1058

Horning, Sandra J

2005

Volltextzugriff (PDF)

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

The New England journal of medicine, 1993-09, Vol.329 (14), p.987-994

1993

Volltextzugriff (PDF)

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1080-1088

1995

Volltextzugriff (PDF)

Long-term survival after histologic transformation of low-grade follicular lymphoma

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1726-1733

1995

Volltextzugriff (PDF)

Introduction: ASCO-ESMO Consensus Statement on Quality Cancer Care

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3497-3497

2006

Volltextzugriff (PDF)

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

Journal of clinical oncology, 1998-01, Vol.16 (1), p.48-55

1998

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(118)

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(102)
Humans
(95)
Oncology
(63)
Biological And Medical Sciences
(57)
Adult
(56)
Medical Sciences
(56)
Male
(55)
Female
(52)
Middle Aged
(50)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)
Hematologic And Hematopoietic Diseases
(34)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(32)
Hematology
(30)
Combined Modality Therapy
(29)
Adolescent
(25)
Aged
(21)
Follow-Up Studies
(21)
Hodgkin Disease - Drug Therapy
(20)
Pharmacology. Drug Treatments
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Treatment approaches to the low-grade lymphomas

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

Natural history of and therapy for the indolent non-Hodgkin's lymphomas

Burkitt's Lymphoma — The Message from Microarrays

Follicular lymphoma : Have we made any progress?

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

Something old, something few, something subjective, something déjà vu

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease

Future directions in radioimmunotherapy for B-cell lymphoma

Introduction: ASCO-ESMO consensus statement on quality cancer care

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory hodgkin's disease : Analysis of the Stanford University results and prognostic indices

Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492

Optimizing rituximab in B-cell lymphoma

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

Long-term survival after histologic transformation of low-grade follicular lymphoma

Introduction: ASCO-ESMO Consensus Statement on Quality Cancer Care

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

Suchergebnisse filtern